| Titre : | Catatonic syndrome : from detection to therapy (2016) |
| Auteurs : | MADIGAND J ; LEBAIN P ; CALLERY G ; DOLLFUS S |
| Type de document : | Article |
| Dans : | ENCEPHALE (4 vol 42, 2016) |
| Article en page(s) : | 340-345 |
| Note générale : | Annexes/Bibliogr. |
| Descripteurs |
[SANTEPSY] CATATONIE [SANTEPSY] DIAGNOSTIC DIFFERENTIEL [SANTEPSY] PRISE EN CHARGE [SANTEPSY] REVUE DE LA LITTERATURE [SANTEPSY] SCHIZOPHRENIE [SANTEPSY] SISMOTHERAPIE [SANTEPSY] THERAPEUTIQUE MEDICAMENTEUSE |
| Mots-clés libres: | ECHELLE D EVALUATION |
| Résumé : | As a result of its different forms and developments, catatonic syndrome can be associated with many organic and psychiatric etiologies and confused with a variety of diagnoses. In addition to its organic complications, malignant catatonia can also be extremely severe. Several diagnostic scales are described, those of Bush and Peralta being the most widely used. Despite the recent development of the DSM-5, we can regret the lack of progress in the international classifications concerning both the recognition of the etiological diversity of this syndrome and in the clinical and therapeutic approaches to it. The diagnosis is based solely on clinical data, and needs to be completed by information from paraclinical settings, particularly with respect to detecting organic etiology. The first-line treatment is still based on the use of certain benzodiazepines or benzodiazepine-like agents such as lorazepam, diazepam and zolpidem. If the first or second line fails, or in case of malignant catatonia, electroconvulsive therapy is recommended. For the periodic form, no large-sample study has been performed on long-term treatment. A few case reports suggest the use of lithium in periodic catatonia, specifically to prevent recurrent episodes or at least to extend the inter-episode intervals. Other studies are in favor of the use of benzodiazepines, with disagreement between gradual discontinuation and long-term treatment. Concerning the management of catatonia in patients with schizophrenia, for whom first-line benzodiazepines are often insufficient, certain atypical antipsychotics such as clozapine or quetiapine appear efficient. These data are also applicable to children and adolescents. [résumé d'auteur] |
| En ligne : | http://www.em-premium.com/article/1073767 |
Bibliothèque Médicale et Professionnelle
Bibliothèque Médicale & Professionnelle
Accueil
Sélection de la langue
Se connecter
Adresse
Bibliothèque Médicale et Professionnelle04 74 52 28 07
contact
